Diabetes and Endocrine Flashcards

1
Q

Levothyroxine MOA

A

synthetic T4 and some of the T4 is converted to T3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Levothyroxine Use

A

any type of hypothyroidism
thyroidectomy
myxedema coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Levothyroxine A/E

A

thyrotoxicosis: (hyperthyroidism) increased HR, A fib, angina, chest pain, tremors, wt. loss, diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Levothyroxine patient education

A

take on an empty stomach about 30-60 minutes before a meal, avoid changing brands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

levothyroxine monitoring

A

Q3mo until maintenance dose is reached, then annually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

liothyronine

A

synthetic T3, works faster and is used for myxedema coma when a faster action is needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Propylthiouracil (PTU) MOA

A

inhibits thyroid hormone synthesis and also decreases conversion of T4 to T3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PTU use

A

hyperthyroidism
thyrotoxicosis
preferred drug for pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

PTU A/E

A

agranulocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PTU dosing

A

2-3 times a day, could be concern for nonadherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PTU and pregnancy

A

crosses the placenta more poorly than other drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Methimazole MOA

A

prevents oxidation of iodine and incorporation of iodine into tyrosine
inhibits peroxidase, the enzyme that catalyzes the oxidation process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Methimazole Use

A

overall the safer antithyroid drug
graves disease
thyroid cancer, per surgery for thyroidectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Methimazole contraindications

A

PREGNANCY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Methimazole A/E

A

Agranulocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sulfonylureas 1st gen drugs

A

Chlorpropamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Sulfonylureas 2nd gen drugs

A

Glimepiride
Glipizide
Glyburide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Sulfonylureas MOA

A

stimulates the pancreas to release insulin, increases sensitivity to insulin at the receptor sites (muscle cells),
decrease hepatic glucose production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Sulfonylureas Uses

A

T2DM only, not the first line drug– 2nd line drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Sulfonylureas contraindications

A

pregnancy– not approved but still given

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Sulfonylureas A/E

A
hypoglycemia
cardiotoxicity/ cardiac effects 
hepatotoxicity/ liver effects 
wt. gain
GI disturbances are #1--lasting about 3 wk (diarrhea, nausea, flatas)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Sulfonylureas Drug interactions

A

Disulfiram like reaction with alcohol
Beta blockers – mask effects of hypoglycemia
antifungals, corticosteroids, thiazide diuretics, antidepressants all increase BG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Biguanide drug

A

Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Metformin MOA

A
increase sensitivity to insulin 
decrease hepatic production of glucose
decrease intestinal absorption of glucose
decreases need for insulin
decreases postprandial BG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Metformin Use
T2DM 1st line treatment prediabetes pregnancy
26
Metformin A/E
``` diarrhea decreased appetite nausea -- GI effects will go away after a tolerance is built up wt loss *lactic acidosis -- must stop drug ```
27
Metformin drug interactions
alcohol | cimetidine
28
Metformin contraindications
renal disease GFR <45 receiving contrast dye acutely ill
29
Metformin patient educations
does not cause hypoglycemia
30
Metformin nursing implementations
delay T2Dm, more effective in <60 y/o and underweight, stop 1-2 days before and after procedure where contrast dye is used
31
Thiazolidinediones (TZD) drugs
Pioglitazone | Rosiglitazone
32
TZD MOA
decreases insulin resistance by increasing insulin action at receptors and post receptor level in hepatic and peripheral tissues
33
TZD A/E
fluid retention: wt gain, congestive HF hepatotoxicity hypoglycemia
34
TZD drug interactions
decrease effects of birth controls often used in combo with other drugs can be used as monotherapy
35
TZD monitoring
wt gain, SOB, chest pain, fluid retention can be used in mild CHF only check LFTs
36
Alpha-glucosidase enzyme inhibitor drugs
Miglitol | Acarbose
37
A-glucosidase enzyme inhibitor MOA
delays breakdown of CHO in the small intestine | ** does not stimulate insulin secretion
38
A-glucosidase enzyme inhibitor A/E
wt. gain | GI effects
39
A-glucosidase enzyme inhibitor Patient education
dont eat, dont take blocks breakdown of sucrose if hypoglycemic give glucose tabs because candy will not work
40
Meglitinide drug
Repaglinide
41
Repaglinide MOA
stimulates insulin secretion by inhibition of ATP sensitive K channels in beta cells
42
Repaglinide A/E
``` hypoglycemia GI effects HA chest pain UTI ```
43
Repaglinide drug interactions
usually given with metformin
44
Repaglinide Patient education
take before a meal, dont take if dont eat
45
DPP4 inhibitor drug
Sitagliptin
46
Sitagliptin MOA
Blocks enzyme, increasing the release of insulin inactivates incretin hormones GIP-1 and GLP inhibits the inhibitor increasing insulin
47
Sitagliptin Use
3rd line choice drug | only to be used in patients who produce insulin
48
Sitagliptin A/E
``` hypoglycemia HA pharyngitis arthritis pancreatitis angioedema anaphylaxis SJS ```
49
Sitagliptin dosing
decrease dose in renal impairment
50
Sitagliptin Patient education
can be taken with or without food
51
SGLT-2 drugs
Canagliflozin | Dapagliflozin
52
SGLT-2 MOA
blocks reabsorption of glucose in the renal tubules
53
SGLT -2 A/E
UTI fungal infections in women postural hypotension
54
SGLT-2 contraindiaction
GFR<45
55
Incretin mimetics drug
Exenatide
56
Exenatide MOA
causes release of endogenous incretin hormones (GIP-1) slows gastric emptying stimulates release of glucose dependant insulin inhibits postprandial glucose release
57
Exenatide Use
T2DM only | injectable
58
Exenatide A/E
``` hypoglycemia with sulfonylureas injection site reaction **pancreatitis renal impairment fetal harm angioedema anaphylaxis **thyroid C-cell tumor (cancer) ```
59
Exenatide drug interactions
decreases absorption of other PO drugs | hypoglycemia with alcohol
60
Exenatide nursing implementations
give PO drugs before this medication
61
regular insulin
short acting
62
regular insulin onset
30-60 min
63
regular insulin peak
1-5hr
64
regular insulin duration
6-10 hr
65
lispro, aspart
rapid acting insulin
66
lispro onset
15-30 min
67
lispro peak
0.5-2.5 hr
68
lispro duration
3-6hr
69
Aspart onset
10-20 min
70
Aspart peak
1-3 hr
71
Aspart duration
3-5 hr
72
Lispro, Aspart, regular insulins mix
with NPH only
73
Lispro good for
those who dont eat regularly
74
NPH
intermediate acting insulin
75
NPH onset
1-2 hr
76
NPH peak
6-14hr
77
NPH duration
16-24 hr
78
NPH dosing
BID morning and evening
79
70/30 mix
70% NPH, 30% regular insulin | given to people who cannot afford NPH and regular separately, and elderly people, poor dexterity
80
Glargine (lantus), levemir
long acting insulin
81
Glargine onset
2-4 hr
82
Glargine peak
peakless
83
Glargine duration
20-24
84
levemir onset
2hr
85
levemir peak
peakless
86
levemir duration
24hr
87
insulin patient education
``` disposal of needles and syringes storage of syringes do not reuse needles calculation of insulin adjustment: 1-2 unit increase every 3-4 days correct lows first ```
88
Insulin A/E
hypoglycemia lipodystrophy -- give less injections at the site atrodystrophy -- give more injections at the site
89
regular insulin route
IV or subQ
90
Glargine/ Levemir education
keep extra bottles in refrigerator, any bottle that is being used should be kept outside of the refrigerator and is good for 30 days
91
refrigerated insulin causes
hyperdystrophy, and atrodystrophy
92
Thyrotoxicosis-- Afib treatment
propranolol